STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2541 by analyst upside · 2026-06-27
SYK
Stryker Corporation
Healthcare · Market Cap $128B · P/E 36.6x
ANALYST PRICE TARGET
+16.3%
implied upside to consensus target
Current Price $332.71
Consensus Target $386.8
Bull Target $465.0
Bear Target $315.0
Analysts Covering 25
ANALYST CONSENSUS - BUY
Strong Buy
7
Buy
11
Hold
7
Sell
0
52-Week Low $281.0
52-Week High $404.87
YTD Return -4.2%
FUNDAMENTALS
Market Cap $128B
P/E Ratio (TTM) 36.6x
Forward P/E 19.9x
EPS (TTM) $9.08
PEG Ratio 1.49
Dividend Yield 1.06%
Revenue (TTM) $25.3B
Profit Margin 13.2%
52-WEEK RANGE
52-Week Low $281.0
52-Week High $404.87
Current Price $332.71
Bear Target $315.0
Bull Target $465.0
● Now $332.71 ● Target $386.8
TRADING DATA
Avg Volume 2.5M
YTD Return -4.2%
Analyst Count 25
Consensus Buy
Upside to Target +16.3%
Last Updated 2026-06-27

ANALYST SUMMARY

Stryker Corporation (SYK) is currently trading at $332.71 with a Wall Street consensus price target of $386.8, implying potential upside of 16.3% over the next 12 months. 25 analysts currently cover SYK, with a consensus rating of Buy - 72% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $465.0, while the most cautious has a target of $315.0.

SYK operates in the Healthcare sector with a market capitalisation of $128B. The stock is down 4.2% year-to-date and is currently trading near the lower end of its 52-week range of $281.0 – $404.87.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SYK, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Leerink Partners — Reiterated
Outperform → Outperform 2026-06-05 29% win rate (7 calls)
Truist Securities reit
Hold → Hold 2026-05-04 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-05-04 Building track record
Canaccord Genuity — Reiterated
Buy → Buy 2026-05-01 Building track record
JP Morgan — Reiterated
Overweight → Overweight 2026-05-01 43% win rate (7 calls)
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-05-01 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-05-01 Building track record
Needham — Reiterated
Buy → Buy 2026-05-01 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
25/30
Consensus clarity
21/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →